Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mack

Showing results (91-100 of 214) with videos related to

Pageof 22
Sort By:
JAMA Cardiology|May 4, 2017
Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and RegistryNirat Beohar, Darshan Doshi, Vinod Thourani, et al.
Arthritis and Rheumatism|April 1, 2009
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled studyArthur Kavanaugh, Iain McInnes, Philip Mease, et al.
Journal of the American College of Cardiology|January 14, 2022
Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance MetricAmgad Mentias, Neil Keshvani, Milind Y Desai, et al.
Journal of the American College of Cardiology|December 20, 2014
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacementPhilippe Généreux, David J Cohen, Michael Mack, et al.
Annals of the Rheumatic Diseases|November 20, 2012
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL studyArthur Kavanaugh, Iain B McInnes, Philip J Mease, et al.
The American Journal of Cardiology|September 4, 2017
Usefulness of Balloon Aortic Valvuloplasty in the Management of Patients With Aortic StenosisMolly Szerlip, Mani Arsalan, Molly C Mack, et al.
Journal of the American College of Cardiology|March 12, 2016
Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United StatesPaul Sorajja, Michael Mack, Sreekanth Vemulapalli, et al.
Journal of the American College of Cardiology|August 24, 2019
Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert PanelJosep Rodés-Cabau, Kenneth A Ellenbogen, Andrew D Krahn, et al.
The Annals of Thoracic Surgery|September 22, 2015
The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation SystemJonathan M Philpott, Christian W Zemlin, James L Cox, et al.
Arthritis and Rheumatism|November 1, 2008
Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trialRobert D Inman, John C Davis, Désirée van der Heijde, et al.
Pageof 22

Showing results (91-100 of 214) with videos related to

Sort By:
Pageof 22
JAMA Cardiology|May 4, 2017
Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and RegistryNirat Beohar, Darshan Doshi, Vinod Thourani, et al.
Arthritis and Rheumatism|April 1, 2009
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled studyArthur Kavanaugh, Iain McInnes, Philip Mease, et al.
Journal of the American College of Cardiology|January 14, 2022
Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance MetricAmgad Mentias, Neil Keshvani, Milind Y Desai, et al.
Journal of the American College of Cardiology|December 20, 2014
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacementPhilippe Généreux, David J Cohen, Michael Mack, et al.
Annals of the Rheumatic Diseases|November 20, 2012
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL studyArthur Kavanaugh, Iain B McInnes, Philip J Mease, et al.
The American Journal of Cardiology|September 4, 2017
Usefulness of Balloon Aortic Valvuloplasty in the Management of Patients With Aortic StenosisMolly Szerlip, Mani Arsalan, Molly C Mack, et al.
Journal of the American College of Cardiology|March 12, 2016
Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United StatesPaul Sorajja, Michael Mack, Sreekanth Vemulapalli, et al.
Journal of the American College of Cardiology|August 24, 2019
Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert PanelJosep Rodés-Cabau, Kenneth A Ellenbogen, Andrew D Krahn, et al.
The Annals of Thoracic Surgery|September 22, 2015
The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation SystemJonathan M Philpott, Christian W Zemlin, James L Cox, et al.
Arthritis and Rheumatism|November 1, 2008
Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trialRobert D Inman, John C Davis, Désirée van der Heijde, et al.
Pageof 22